Skip to content
Screener

AptarGroup ATR Pharma — Restructuring initiatives

Other segment segments

Beauty
$1.3M—
Closures
$249K—

Similar metrics at other companies

Icahn Enterprises logo
IEPPharma — Restructuring Charges
$1M—
Johnson & Johnson logo
JNJOrthopaedics Restructuring Plan — Restructuring
$76.75M—
Crown Holdings logo
CCKOther — Restructuring
$0-100%
UL Solutions logo
ULSConsumer — Restructuring
-$1M0.0%
UL Solutions logo
ULSIndustrial — Restructuring
$1M—
Maravai LifeSciences Holdings, Inc. logo
MRVICorporate — Restructuring
$743K—

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$8.69B-4.7%
Enterprise value$9.9B-2.2%
P/E22.5×-0.8×
P/S2.3×-0.3×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000896622-26-000092
Three Months Ended March 31,20262025
Restructuring Initiatives by Segment:
Pharma$5$190
Beauty1,301395
Closures2491,352
Corporate & Other(469)105
Total Restructuring Initiatives$1,086$2,042

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's pharma — restructuring initiatives?
AptarGroup (ATR) reported pharma — restructuring initiatives of $5K in Q1 2026.
How has AptarGroup's pharma — restructuring initiatives changed year-over-year?
AptarGroup's pharma — restructuring initiatives decreased by 97.4% year-over-year, from $190K to $5K.
What does pharma — restructuring initiatives mean?
Costs associated with organizational changes, facility consolidations, or workforce reductions within the Pharma business segment. These expenses are typically non-recurring and reflect management's efforts to optimize operational efficiency and align the cost structure with long-term strategic goals.

Ask your AI about AptarGroup's pharma — restructuring initiatives.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude